In our December 2023 issue of Medical Liability Monitor, we summarize results from the third quarter for medical professional liability (MPL) specialty writers. The data used in our analysis covers 20 years and consists of aggregate statutory financial information compiled from S&P Global Market Intelligence. The current composite includes 176 MPL specialty companies with total direct written premium of more than $6.6 billion in 2022. In this issue, we discuss the following observations: 

• Premium growth slowed
• Indemnity payments continued to surge after the COVID-19 slowdown
• Underwriting expenses are rising
• Investment income came roaring back
• Dividend levels neared a two-decade low